Baroness Susan Greenfield is a pioneering neuroscientist and entrepreneur whose work delves into the brain’s most profound mysteries, from consciousness to neurodegenerative diseases like Alzheimer’s and Parkinson's. As the founder and CEO of the biotech company Neuro-Bio, she leads groundbreaking efforts to develop new treatments for Alzheimer’s based on her research into novel brain mechanisms.
Susan has made significant contributions to understanding how technology affects the human brain, sparking vital conversations about how innovations like social media and gaming shape our cognition, creativity, and identity. Her book Mind Change explores these themes in depth, positioning her as a leading voice on the intersection of neuroscience and modern life.
A passionate advocate for women in science, Susan authored the influential SET Fair report for the UK government in 2002, which highlighted the systemic barriers faced by women in science, engineering, and technology and provided actionable recommendations to improve recruitment, retention, and support for women in these fields. Greenfield continues to work tirelessly on initiatives that promote gender equity, aiming to level the playing field and create a more inclusive environment for future generations of female scientists.
Throughout her career, Susan has been recognized with numerous accolades, including being appointed a CBE and receiving a Life Peerage in 2001. She holds 32 honorary degrees and is a member of prestigious institutions like the Royal Society of Edinburgh and the French L’Ordre National de la Légion d’Honneur. She also served as Adelaide's "Thinker in Residence" from 2004 to 2005, where she advised the South Australian government on how science and technology could drive economic development.
Through her research, writing, and public speaking, Susan bridges the gap between cutting-edge science and its implications for society, offering insights that resonate with both experts and the public alike.